Journal articles on the topic 'Immune necrotizing myopathies'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Immune necrotizing myopathies.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Mohammed, Abdel Gaffar A., Ayanda Gcelu, Farzana Moosajee, Stella Botha, and Asgar Ali Kalla. "Immune Mediated Necrotizing Myopathy: Where do we Stand?" Current Rheumatology Reviews 15, no. 1 (2018): 23–26. http://dx.doi.org/10.2174/1573397114666180406101850.
Full textAllenbach, Yves, and Olivier Benveniste. "Peculiar clinicopathological features of immune-mediated necrotizing myopathies." Current Opinion in Rheumatology 30, no. 6 (2018): 655–63. http://dx.doi.org/10.1097/bor.0000000000000547.
Full textAkbar, Shalla, Sandhya Dasaraju, and Osama Elkadi. "A Case of Immune-Mediated Necrotizing Myopathy With Associated Skeletal Muscle Involvement by Sarcoid Granulomata: A Rare Association." American Journal of Clinical Pathology 152, Supplement_1 (2019): S69. http://dx.doi.org/10.1093/ajcp/aqz113.078.
Full textPinal-Fernandez, Iago, and Andrew L. Mammen. "Spectrum of immune-mediated necrotizing myopathies and their treatments." Current Opinion in Rheumatology 28, no. 6 (2016): 619–24. http://dx.doi.org/10.1097/bor.0000000000000335.
Full textLee, Jong-Mok. "Immune-Mediated Necrotizing Myopathy: A Review for Clinicians." Journal of Electrodiagnosis and Neuromuscular Diseases 24, no. 3 (2022): 57–61. http://dx.doi.org/10.18214/jend.2022.00087.
Full textKnauss, Samuel, Corinna Preusse, Yves Allenbach, et al. "PD1 pathway in immune-mediated myopathies." Neurology - Neuroimmunology Neuroinflammation 6, no. 3 (2019): e558. http://dx.doi.org/10.1212/nxi.0000000000000558.
Full textSwafford, Collin, and E. Steve Roach. "Juvenile Dermatomyositis and the Inflammatory Myopathies." Seminars in Neurology 40, no. 03 (2020): 342–48. http://dx.doi.org/10.1055/s-0040-1705120.
Full textMecoli, Christopher A., Arash H. Lahouti, Robert A. Brodsky, Andrew L. Mammen, and Lisa Christopher-Stine. "High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies." Neurology - Neuroimmunology Neuroinflammation 4, no. 5 (2017): e381. http://dx.doi.org/10.1212/nxi.0000000000000381.
Full textChiapparoli, Ilaria, Claudio Galluzzo, Carlo Salvarani, and Nicolò Pipitone. "A glance into the future of myositis therapy." Therapeutic Advances in Musculoskeletal Disease 14 (January 2022): 1759720X2211002. http://dx.doi.org/10.1177/1759720x221100299.
Full textPark, Sunha, Dae-Hyun Jang, Jae-Min Kim, and Nara Yoon. "Prominent Asymmetric Muscle Weakness and Atrophy in Seronegative Immune-Mediated Necrotizing Myopathy." Diagnostics 11, no. 11 (2021): 2064. http://dx.doi.org/10.3390/diagnostics11112064.
Full textAllenbach, Yves, Louiza Arouche-Delaperche, Corinna Preusse, et al. "Necrosis in anti-SRP+ and anti-HMGCR+myopathies." Neurology 90, no. 6 (2018): e507-e517. http://dx.doi.org/10.1212/wnl.0000000000004923.
Full textBondarenko, Inna B., Liubov A. Ponomareva, and Elena N. Popova. "Clinical types of lung disease in polymyositis and dermatomyositis." Clinical review for general practice 2, no. 4 (2021): 34–39. http://dx.doi.org/10.47407/kr2021.2.4.00058.
Full textPetreski, Tadej, Nejc Piko, Timotej Petrijan, Benjamin Dvoršak, Radovan Hojs, and Sebastjan Bevc. "Statin-Associated Necrotizing Myopathy Leading to Acute Kidney Injury: A Case Report." Case Reports in Nephrology and Dialysis 11, no. 2 (2021): 129–35. http://dx.doi.org/10.1159/000515584.
Full textSilva, André Macedo Serafim, Eliene Dutra Campos, and Edmar Zanoteli. "Inflammatory myopathies: an update for neurologists." Arquivos de Neuro-Psiquiatria 80, no. 5 suppl 1 (2022): 238–48. http://dx.doi.org/10.1590/0004-282x-anp-2022-s131.
Full textKamperman, Renske G., Anneke J. van der Kooi, Marianne de Visser, Eleonora Aronica, and Joost Raaphorst. "Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review." International Journal of Molecular Sciences 23, no. 8 (2022): 4301. http://dx.doi.org/10.3390/ijms23084301.
Full textFischer, Norina, Corinna Preuße, Josefine Radke, et al. "Sequestosome‐1 (p62) expression reveals chaperone‐assisted selective autophagy in immune‐mediated necrotizing myopathies." Brain Pathology 30, no. 2 (2019): 261–71. http://dx.doi.org/10.1111/bpa.12772.
Full textStenzel, W., H. H. Goebel, and E. Aronica. "Review: Immune-mediated necrotizing myopathies - a heterogeneous group of diseases with specific myopathological features." Neuropathology and Applied Neurobiology 38, no. 7 (2012): 632–46. http://dx.doi.org/10.1111/j.1365-2990.2012.01302.x.
Full textTrandafir, Andreea, Violeta Claudia Bonjincă, Delia Tulba, and Gelu Onose. "An odd case of immune-mediated necrotizing myopathy, complicated with sagittal, transverse and sigmoid sinus thrombosis." Balneo and PRM Research Journal 14, Vol.14, no. 4 (2023): 630. http://dx.doi.org/10.12680/balneo.2023.630.
Full textBonanno, S., and L. Maggi. "VP.43 Immune-mediated necrotizing myopathies: clinical-serological features of a large Italian cohort of patients." Neuromuscular Disorders 32 (October 2022): S83. http://dx.doi.org/10.1016/j.nmd.2022.07.174.
Full textKolomeychuk, A. A. "Capabilities of magnetic resonance imaging in the diagnosis of idiopathic inflammatory myopathies." Rheumatology Science and Practice 61, no. 6 (2024): 689–99. http://dx.doi.org/10.47360/1995-4484-2023-689-699.
Full textSan, Pyae Phyo, Nicholas Davies, Venkataramanan Srinivasan, et al. "175 A case series of anti-HMGCR immune mediated necrotizing myopathy: the West Midlands data." Journal of Neurology, Neurosurgery & Psychiatry 93, no. 9 (2022): e2.134. http://dx.doi.org/10.1136/jnnp-2022-abn2.219.
Full textZerlotin, Roberta, Marco Fornaro, Mariella Errede, et al. "Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance." International Journal of Molecular Sciences 24, no. 3 (2023): 2469. http://dx.doi.org/10.3390/ijms24032469.
Full textLee, Seung-Ah, Hyun Joon Lee, Bum Chun Suh, et al. "Clinical significance of anti-NT5c1A autoantibody in Korean patients with inflammatory myopathies." PLOS ONE 18, no. 4 (2023): e0284409. http://dx.doi.org/10.1371/journal.pone.0284409.
Full textMatsuda, Nozomu, Shunsuke Kobayashi, Osamu Hasegawa, et al. "Subclinical involvement of the trunk muscles in idiopathic inflammatory myopathies." Acta Radiologica Open 11, no. 2 (2022): 205846012210757. http://dx.doi.org/10.1177/20584601221075796.
Full textKurashige, Takashi, Tomomi Murao, Naoko Mine, et al. "Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations." Journal of Neuropathology & Experimental Neurology 79, no. 4 (2020): 448–57. http://dx.doi.org/10.1093/jnen/nlaa006.
Full textKhelkovskaia-Sergeeva, A., O. Desinova, M. Starovoytova, L. P. Ananyeva, M. Cherkasova та R. Shayakhmetova. "AB0444 СLINICAL-IMMUNOLOGICAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY MYOPATHIES". Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 1249.3–1250. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3101.
Full textde Souza, Jean Marcos, Leonardo Santos Hoff, and Samuel Katsuyuki Shinjo. "Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies." Rheumatology International 39, no. 7 (2019): 1201–12. http://dx.doi.org/10.1007/s00296-019-04254-3.
Full textde Oliveira, Diego Sales, Isabela Bruna Pires Borges, Suely Kazue Nagahashi Marie, Antonio Marcondes Lerario, Sueli Mieko Oba-Shinjo, and Samuel Katsuyuki Shinjo. "Exercise training attenuates skeletal muscle fat infiltration and improves insulin pathway of patients with immune-mediated necrotizing myopathies and dermatomyositis." Archives of Rheumatology 38, no. 2 (2022): 189–99. http://dx.doi.org/10.46497/archrheumatol.2023.9257.
Full textDanielsson, Olof, Björn Lindvall, Istvan Gati, and Jan Ernerudh. "Classification and Diagnostic Investigation in Inflammatory Myopathies: A Study of 99 Patients." Journal of Rheumatology 40, no. 7 (2013): 1173–82. http://dx.doi.org/10.3899/jrheum.120804.
Full textXiong, Anji, Guancui Yang, Zhuoyao Song, et al. "Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series." Therapeutic Advances in Neurological Disorders 14 (January 2021): 175628642199891. http://dx.doi.org/10.1177/1756286421998918.
Full textRobert, M., L. Lessard, T. Fenouil, et al. "POS0490 USEFULNESS OF MHC-II IMMUNO-STAINING ON MUSCLE BIOPSIES IN IDIOPATHIC INFLAMMATORY MYOPATHIES." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 499.2–500. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5186.
Full textAllenbach, Y., A. Rigolet, L. Drouot, et al. "P.14.11 Auto-immune necrotizing myopathies with anti-HMGCR antibodies are related to statin-exposure only for a minority of cases." Neuromuscular Disorders 23, no. 9-10 (2013): 816–17. http://dx.doi.org/10.1016/j.nmd.2013.06.619.
Full textMeyer, A., L. Messer, J. Goetz, et al. "Immune-mediated necrotizing myopathies are serologically heterogeneous and autoantibodies may predict their clinical phenotype: two cases associated with anti-Pl7 antibodies." Scandinavian Journal of Rheumatology 43, no. 1 (2014): 81–83. http://dx.doi.org/10.3109/03009742.2013.864421.
Full textPepper, Elizabeth, Lilian Vilar, and Ian M. Ward. "Clinical Characteristics and Prognostic Value of Ro52/SSA Antibodies in Idiopathic Inflammatory Myopathies." JCR: Journal of Clinical Rheumatology 29, no. 7 (2023): 347–53. http://dx.doi.org/10.1097/rhu.0000000000002015.
Full textRobert, M., L. Gallay, P. Petiot, et al. "POS0862 INAUGURAL DROPPED HEAD SYNDROME AND CAMPTOCORMIA IN INFLAMMATORY MYOPATHIES." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 725.1–725. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1605.
Full textLopez, B., C. Fuego-Varela, J. Galloway, and P. Gordon. "THU0335 IS CARDIOVASCULAR RISK IN INFLAMMATORY MYOPATHIES UNDERESTIMATED?" Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 398.2–399. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4926.
Full textCorrales-Selaya, C., D. Martínez-López, D. Prieto-Peña, J. L. Martín-Varillas, and R. Blanco. "AB0874 EPIDEMIOLOGY AND CLINICAL FEATURES OF IDIOPATHIC INFLAMMATORY MYOPATHIES IN SINGLE REGION IN NORTHERN SPAIN." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1651–52. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2852.
Full textMusset, Lucile, Yves Allenbach, Olivier Benveniste, et al. "Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study." Autoimmunity Reviews 15, no. 10 (2016): 983–93. http://dx.doi.org/10.1016/j.autrev.2016.07.023.
Full textLarco Rojas, X. E., S. Sáez-Álvarez, P. Pérez-García, et al. "AB0706 Demographic, clinical and serological characteristics in Idiopathic Inflammatory Myopathies. The role of specific antibodies." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 1479.3–1480. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3657.
Full textSuzuki, K., Y. Kondo, S. Ishigaki, S. Takanashi, and Y. Kaneko. "AB1630 RISK FACTORS FOR CARDIAC INVOLVEMENT IN IDIOPATHIC INFLAMMATORY MYOPATHIES." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 2049.1–2049. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1969.
Full textTurner, Richard Myles, and Munir Pirmohamed. "Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components." Journal of Clinical Medicine 9, no. 1 (2019): 22. http://dx.doi.org/10.3390/jcm9010022.
Full textDourado, E., A. T. Melo, P. Martins, et al. "POS0891 REUMA.pt/MYOSITIS – THE PORTUGUESE REGISTRY OF INFLAMMATORY MYOPATHIES." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 742. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3259.
Full textUruha, Akinori, Atsuko Nishikawa, Rie S. Tsuburaya, et al. "Sarcoplasmic MxA expression." Neurology 88, no. 5 (2016): 493–500. http://dx.doi.org/10.1212/wnl.0000000000003568.
Full textGalindo-Feria, A. S., B. Horuluoglu, J. Day, et al. "POS0883 DETECTION OF AUTOANTIBODIES AGAINST MUSCLE-SPECIFIC FOUR-AND-A-HALF-LIM DOMAIN 1 (FHL1) IN INFLAMMATORY MYOPATHIES: RESULTS FROM A SINGLE-CENTER COHORT." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 697.3–698. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3640.
Full textLi, Wenli, Chuiwen Deng, Hanbo Yang, et al. "Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies." Neurology - Neuroimmunology Neuroinflammation 10, no. 5 (2023): e200143. http://dx.doi.org/10.1212/nxi.0000000000200143.
Full textZhao, Bing, Tingjun Dai, Dandan Zhao, et al. "Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy." Neurology - Neuroimmunology Neuroinflammation 9, no. 4 (2022): e1184. http://dx.doi.org/10.1212/nxi.0000000000001184.
Full textRosa, C., K. Chaudhuri, T. Blake, T. Potter, and S. Banerjee. "AB0888 CLINICAL CHARACTERISTICS OF ANTI HMGCOA REDUCTASE ANTIBODY POSITIVE IMMUNE MEDIATED NECROTIZING MYOPATHY: CASE SERIES OF 5 PATIENTS FROM A TERTIARY CENTRE." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1659.1–1659. http://dx.doi.org/10.1136/annrheumdis-2023-eular.5438.
Full textAdsuara de Sousa, L. F., R. G. Misse, L. De Macedo Dos Santos, et al. "POS0887 TRANSCRANIAL ELECTRICAL STIMULATION IS SAFE AND EFFICIENT IN PATIENTS WITH SYSTEMIC AUTOIMMUNE MYOPATHIES." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 699.2–700. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3723.
Full textGraf, M., A. S. L. Von Stuckrad, A. Uruha, et al. "POS0183 SIGLEC1 AS A TYPE I INTERFERON BIOMARKER IN IDIOPATHIC INFLAMMATORY MYOPATHIES." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 305.1–305. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2816.
Full textDe Lorenzo, R., S. Cavalli, F. Bonomi, et al. "AB0567 CHARACTERIZATION OF PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHY AND MYOCARDIAL INVOLVEMENT: A MONO-CENTRIC EXPERIENCE." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 1580.3–1580. http://dx.doi.org/10.1136/annrheumdis-2020-eular.6248.
Full text